title: Removing the black box warning for depot medroxyprogesterone acetate.
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Kaunitz
authors.forename: David A
authors.initials: DA
authors.lastname: Grimes
mesh_terms: D015519:Bone Density / Q000187:drug effects*; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D004348:Drug Labeling / Q000592:standards*; D004363:Drug Utilization / Q000706:statistics & numerical data*; D005260:Female; D050723:Fractures, Bone / Q000139:chemically induced*; D006801:Humans; D007436:Intrauterine Devices, Medicated / Q000009:adverse effects*; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects* / Q000494:pharmacology*; D017698:Postmenopause; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011247:Pregnancy; D055656:Prescriptions / Q000706:statistics & numerical data*
chemical_list: D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate